信立泰连跌3天，汇添富基金旗下1只基金位列前十大股东

Group 1 - The core point of the news is that Shenzhen Sinopharm Co., Ltd. has experienced a decline in stock price over three consecutive trading days, with a cumulative drop of -2.68% [1] - Sinopharm, established in 1998 and listed on the Shenzhen Stock Exchange in 2009, is an innovative pharmaceutical company focused on research, production, and sales [1] - The fund "Huitianfu Medical Service Flexible Allocation Mixed A" has entered the top ten shareholders of Sinopharm, marking its new entry in the second quarter of this year [1] Group 2 - The fund has achieved a year-to-date return of 61.88%, ranking 15th among 2,272 similar funds [2] - The fund's performance over different time frames shows a near-term decline of -0.20% over the past week, but significant gains of 11.24% over the past month and 64.47% year-to-date [2] - The fund manager, Zhang Wei, has a strong background in biomedical studies and has held various positions in the pharmaceutical research field [3][4]